MX2007008923A - Microserpentin implantable con superficie de porosidad microscopica. - Google Patents

Microserpentin implantable con superficie de porosidad microscopica.

Info

Publication number
MX2007008923A
MX2007008923A MX2007008923A MX2007008923A MX2007008923A MX 2007008923 A MX2007008923 A MX 2007008923A MX 2007008923 A MX2007008923 A MX 2007008923A MX 2007008923 A MX2007008923 A MX 2007008923A MX 2007008923 A MX2007008923 A MX 2007008923A
Authority
MX
Mexico
Prior art keywords
microcoil
implantable
porosity surface
microscopic porosity
voids
Prior art date
Application number
MX2007008923A
Other languages
English (en)
Inventor
Michael Henson
Robert A Stern
Original Assignee
Micrus Endovascular Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Micrus Endovascular Corp filed Critical Micrus Endovascular Corp
Publication of MX2007008923A publication Critical patent/MX2007008923A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/1214—Coils or wires
    • A61B17/1215—Coils or wires comprising additional materials, e.g. thrombogenic, having filaments, having fibers, being coated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • A61B17/12113—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/1214—Coils or wires
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12181—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices
    • A61B17/1219—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices expandable in contact with liquids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00004—(bio)absorbable, (bio)resorbable, resorptive
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time

Abstract

Un microserpentin (10) vasooclusivo para tratamiento terapeutico de la vasculatura de un paciente incluye una superficie con una pluralidad de huecos o poros (18) en la misma, y un material terapeutico o bioactivo dispuesto dentro de la pluralidad de huecos o poros (18). El material terapeutico o bioactivo dentro de la pluralidad de huecos o poros (18) opera para acelerar un proceso de cicatrizacion en la vasculatura de un paciente cuando el microserpentin (10) se introduce en la vasculatura de un paciente.
MX2007008923A 2005-01-26 2006-01-26 Microserpentin implantable con superficie de porosidad microscopica. MX2007008923A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64751605P 2005-01-26 2005-01-26
PCT/US2006/002903 WO2006081407A1 (en) 2005-01-26 2006-01-26 Implantable microcoil with microscopic porosity surface

Publications (1)

Publication Number Publication Date
MX2007008923A true MX2007008923A (es) 2008-02-21

Family

ID=36740855

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007008923A MX2007008923A (es) 2005-01-26 2006-01-26 Microserpentin implantable con superficie de porosidad microscopica.

Country Status (7)

Country Link
US (4) US7361367B2 (es)
EP (1) EP1841367A1 (es)
JP (1) JP2008528196A (es)
CN (1) CN101106948A (es)
CA (1) CA2595891A1 (es)
MX (1) MX2007008923A (es)
WO (1) WO2006081407A1 (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7033374B2 (en) * 2000-09-26 2006-04-25 Microvention, Inc. Microcoil vaso-occlusive device with multi-axis secondary configuration
US7700819B2 (en) 2001-02-16 2010-04-20 Kci Licensing, Inc. Biocompatible wound dressing
US7763769B2 (en) 2001-02-16 2010-07-27 Kci Licensing, Inc. Biocompatible wound dressing
US20110054511A1 (en) * 2005-01-26 2011-03-03 Micrus Endovascular Corporation Adding microscopic porosity to the surface of a microcoil to be used for medical implantation
US7361367B2 (en) * 2005-01-26 2008-04-22 Micrus Endovascular Corporation Adding microscopic porosity to the surface of a microcoil to be used for medical implantation
US7469100B2 (en) * 2005-10-03 2008-12-23 Flextronics Ap Llc Micro camera module with discrete manual focal positions
CA2685080A1 (en) 2007-04-24 2008-11-06 Flextronics Ap Llc Small form factor modules using wafer level optics with bottom cavity and flip-chip assembly
CN101842061A (zh) 2007-06-25 2010-09-22 微排放器公司 自扩展假体
WO2009058780A2 (en) * 2007-10-29 2009-05-07 Zimmer, Inc. Medical implants and methods for delivering biologically active agents
US10028747B2 (en) 2008-05-01 2018-07-24 Aneuclose Llc Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm
US10716573B2 (en) 2008-05-01 2020-07-21 Aneuclose Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm
CA2732507A1 (en) * 2008-08-06 2010-02-11 Boston Scientific Scimed, Inc. Vaso-occlusive devices with textured surfaces
DE102009009003A1 (de) * 2009-02-16 2010-08-26 Justus-Liebig-Universität Giessen Implantat
US9358140B1 (en) 2009-11-18 2016-06-07 Aneuclose Llc Stent with outer member to embolize an aneurysm
US8545114B2 (en) 2011-03-11 2013-10-01 Digitaloptics Corporation Auto focus-zoom actuator or camera module contamination reduction feature with integrated protective membrane
JP2014522263A (ja) 2011-05-11 2014-09-04 マイクロベンション インコーポレイテッド 内腔を閉塞するためのデバイス
CN104582589A (zh) * 2012-08-22 2015-04-29 柯惠Lp公司 组织固定装置
WO2014036809A1 (en) * 2012-09-06 2014-03-13 The Hong Kong University Of Science And Technology Endoluminal drug delivery devices with applications in blood vessels
US9011481B2 (en) * 2012-12-30 2015-04-21 Cook Medical Technologies Llc Vascular occlusion device having a jelly fish
ES2701226T3 (es) * 2013-02-19 2019-02-21 Univ Texas Gradientes químicos
WO2015015314A2 (en) 2013-07-31 2015-02-05 EMBA Medical Limited Methods and devices for endovascular embolization
US10010328B2 (en) 2013-07-31 2018-07-03 NeuVT Limited Endovascular occlusion device with hemodynamically enhanced sealing and anchoring
US11484319B2 (en) 2015-01-20 2022-11-01 Neurogami Medical, Inc. Delivery system for micrograft for treating intracranial aneurysms
US10857012B2 (en) 2015-01-20 2020-12-08 Neurogami Medical, Inc. Vascular implant
US10925611B2 (en) 2015-01-20 2021-02-23 Neurogami Medical, Inc. Packaging for surgical implant
US10736730B2 (en) 2015-01-20 2020-08-11 Neurogami Medical, Inc. Vascular implant
WO2016118420A1 (en) 2015-01-20 2016-07-28 Neurogami Medical, Inc. Micrograft for the treatment of intracranial aneurysms and method for use
US10420563B2 (en) 2016-07-08 2019-09-24 Neurogami Medical, Inc. Delivery system insertable through body lumen
CN112754583B (zh) * 2020-12-31 2022-04-15 微创神通医疗科技（上海）有限公司 弹簧圈及其制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US695368A (en) * 1901-08-22 1902-03-11 Russel Bigelow Chair-truck.
US5449382A (en) * 1992-11-04 1995-09-12 Dayton; Michael P. Minimally invasive bioactivated endoprosthesis for vessel repair
US5750585A (en) * 1995-04-04 1998-05-12 Purdue Research Foundation Super absorbent hydrogel foams
US5837313A (en) * 1995-04-19 1998-11-17 Schneider (Usa) Inc Drug release stent coating process
US5749894A (en) * 1996-01-18 1998-05-12 Target Therapeutics, Inc. Aneurysm closure method
US6033582A (en) * 1996-01-22 2000-03-07 Etex Corporation Surface modification of medical implants
US5843172A (en) * 1997-04-15 1998-12-01 Advanced Cardiovascular Systems, Inc. Porous medicated stent
US5928260A (en) * 1997-07-10 1999-07-27 Scimed Life Systems, Inc. Removable occlusion system for aneurysm neck
US8257726B2 (en) * 1997-09-26 2012-09-04 Abbott Laboratories Compositions, systems, kits, and methods of administering rapamycin analogs with paclitaxel using medical devices
US7357942B2 (en) * 1997-09-26 2008-04-15 Abbott Laboratories Compositions, systems, and kits for administering zotarolimus and paclitaxel to blood vessel lumens
US6096175A (en) * 1998-07-17 2000-08-01 Micro Therapeutics, Inc. Thin film stent
US6187024B1 (en) * 1998-11-10 2001-02-13 Target Therapeutics, Inc. Bioactive coating for vaso-occlusive devices
US6238403B1 (en) * 1999-10-04 2001-05-29 Microvention, Inc. Filamentous embolic device with expansible elements
US6602261B2 (en) * 1999-10-04 2003-08-05 Microvention, Inc. Filamentous embolic device with expansile elements
US7427526B2 (en) * 1999-12-20 2008-09-23 The Penn State Research Foundation Deposited thin films and their use in separation and sacrificial layer applications
GB0017148D0 (en) * 2000-07-12 2000-08-30 Isis Innovation An improved bone-implant prosthesis
US6554849B1 (en) * 2000-09-11 2003-04-29 Cordis Corporation Intravascular embolization device
US6723108B1 (en) * 2000-09-18 2004-04-20 Cordis Neurovascular, Inc Foam matrix embolization device
US6506437B1 (en) * 2000-10-17 2003-01-14 Advanced Cardiovascular Systems, Inc. Methods of coating an implantable device having depots formed in a surface thereof
US6953468B2 (en) 2001-06-13 2005-10-11 Cordis Neurovascular, Inc. Occluding vasculature of a patient using embolic coil with improved platelet adhesion
US20030199887A1 (en) * 2002-04-23 2003-10-23 David Ferrera Filamentous embolization device and method of use
US7481821B2 (en) * 2002-11-12 2009-01-27 Thomas J. Fogarty Embolization device and a method of using the same
US20040193246A1 (en) * 2003-03-25 2004-09-30 Microvention, Inc. Methods and apparatus for treating aneurysms and other vascular defects
US7229471B2 (en) * 2004-09-10 2007-06-12 Advanced Cardiovascular Systems, Inc. Compositions containing fast-leaching plasticizers for improved performance of medical devices
US7361367B2 (en) * 2005-01-26 2008-04-22 Micrus Endovascular Corporation Adding microscopic porosity to the surface of a microcoil to be used for medical implantation

Also Published As

Publication number Publication date
CN101106948A (zh) 2008-01-16
US20080152686A1 (en) 2008-06-26
US7361367B2 (en) 2008-04-22
EP1841367A1 (en) 2007-10-10
WO2006081407A1 (en) 2006-08-03
US20060251700A1 (en) 2006-11-09
JP2008528196A (ja) 2008-07-31
US20060251695A1 (en) 2006-11-09
US20080031919A1 (en) 2008-02-07
CA2595891A1 (en) 2006-08-03
US7300661B2 (en) 2007-11-27
US7442382B2 (en) 2008-10-28

Similar Documents

Publication Publication Date Title
MX2007008923A (es) Microserpentin implantable con superficie de porosidad microscopica.
EP2417919A3 (en) Adding microscopic porosity to the surface of a microcoil to be used for medical implantation
WO2008045228A3 (en) Medical devices having porous regions for controlled therapeutic agent exposure or delivery
WO2004010975A3 (en) Controlled drug delivery
WO2005001080A3 (en) Postpartum-derived cells for use in treatment of disease of the heart and circulatory system
NZ591338A (en) Platelet-derived growth factor compositions and methods for the treatment of tendon and ligament injuries
HK1136480A1 (en) Solid dressing for treating wounded tissue
WO2003076604A3 (en) Surgical device for skin therapy or testing
WO2007075981A3 (en) Devices, systems and methods for retracting, lifting, compressing, supporting or repositioning tissues or anatomical structures
WO2007133382A3 (en) Methods, compositions and devices for treating lesioned sites using bioabsorbable carriers
WO2008108987A3 (en) Medical device with a porous surface for delivery of a therapeutic agent
ATE260124T1 (de) Stoffzusammensetzung zur gewebebildung
EP1426066A4 (en) FRUIT PRODUCT FOR THE CONSTRUCTION OF HUMAN BONE FABRIC, METHOD FOR ITS MANUFACTURE AND APPLICATION AREAS
EP2332555A3 (en) Methods of using regenerative cells to promote wound healing
WO2002011782A8 (es) Metodo de produccion de filmes a base de quitosan con capacidad de adherencia celular aumentada, producto obtenido y aplicaciones
WO2003018077A1 (fr) Procede de regeneration osseuse
WO2006022612A3 (en) Methods of using regenerative cells in the treatment of stroke and related diseases and disorders
TW200509872A (en) Methods for preparing medical implants from calcium phosphate cement and medical implants
WO2003039591A3 (de) Allogene vakzine enthaltend eine ein costimulatorisches polypeptid exprimierende tumorzelle
FI972004A0 (fi) Implantoitava laite vaikuttavien aineiden antamiseen kasveille
WO2007089976A3 (en) Local control of inflammation
PL1626750T3 (pl) Biokompatybilny polimer
TW200600103A (en) A method for preserving platelets outside a living body
Choi et al. Treatment of partial thickness burn wounds with cultured epidermal homografts
CA2557884A1 (en) An agent for promoting induction of vascular differentiation, comprising hepatocyte growth factor